CX Institutional Purchases 22,285 Shares of MetLife, Inc. $MET

CX Institutional lifted its position in MetLife, Inc. (NYSE:MET) by 30.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,972 shares of the financial services provider’s stock after buying an additional 22,285 shares during the period. CX Institutional’s holdings in MetLife were worth $7,905,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Allworth Financial LP lifted its stake in MetLife by 13.4% in the second quarter. Allworth Financial LP now owns 10,893 shares of the financial services provider’s stock valued at $876,000 after buying an additional 1,285 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in MetLife by 188.1% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 417,515 shares of the financial services provider’s stock valued at $33,577,000 after acquiring an additional 272,619 shares in the last quarter. Kathmere Capital Management LLC boosted its stake in MetLife by 88.2% in the 2nd quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock worth $509,000 after purchasing an additional 2,965 shares during the period. McElhenny Sheffield Capital Management LLC bought a new position in MetLife during the 2nd quarter worth about $1,608,000. Finally, Zurich Insurance Group Ltd FI acquired a new stake in shares of MetLife in the 1st quarter valued at about $12,060,000. 94.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

MET has been the subject of a number of research reports. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $94.00 and gave the stock an “overweight” rating in a report on Tuesday, December 23rd. Morgan Stanley set a $101.00 price objective on shares of MetLife and gave the company an “overweight” rating in a report on Monday, December 15th. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Keefe, Bruyette & Woods cut their price target on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Finally, UBS Group lowered their target price on MetLife from $96.00 to $95.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.83.

MetLife Stock Performance

Shares of MET opened at $78.30 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.18 and a quick ratio of 0.18. The firm has a 50-day moving average of $78.76 and a 200-day moving average of $79.02. The company has a market cap of $51.59 billion, a PE ratio of 14.75, a price-to-earnings-growth ratio of 0.73 and a beta of 0.76. MetLife, Inc. has a one year low of $65.21 and a one year high of $88.09.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, topping analysts’ consensus estimates of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The business had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. During the same quarter last year, the company posted $1.95 earnings per share. MetLife’s quarterly revenue was down 5.9% on a year-over-year basis. As a group, equities analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife’s dividend payout ratio is presently 42.75%.

Key Headlines Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Board declared a quarterly common-stock dividend of $0.5675 per share (payable Mar 10, record Feb 3), supporting income investors and signaling capital-return stability. MetLife Declares First Quarter 2026 Common Stock Dividend
• Positive Sentiment: MetLife and backers (General Atlantic) completed a second reinsurance deal with Chariot Re, which can improve capital efficiency and reduce underwriting volatility over time. MetLife & General Atlantic-backed Chariot Re complete second reinsurance deal
• Positive Sentiment: MetLife has entered the Irish group life market, a measured geographic/ product expansion that adds modest growth optionality in benefits. MetLife enters Irish market with group life cover
• Neutral Sentiment: MetLife scheduled its Q4 and full-year 2025 earnings release for after market close Feb 4, with a combined earnings/outlook call Feb 5 — a key event that will drive near-term stock moves. MetLife to Hold Combined Earnings and Outlook Conference Call
• Neutral Sentiment: MetLife research highlighted employers’ 2026 focus on cost control, an industry trend that could pressure benefits spend and revenue mix but is not an immediate company-specific shock. MetLife reveals the top priority for employers in 2026
• Negative Sentiment: Evercore ISI downgraded MetLife from outperform to hold/in-line, removing a buy tilt and adding near-term selling pressure as investors adjust expectations. MET MetLife just downgraded at Evercore ISI
• Negative Sentiment: Bank of America trimmed its price target slightly (reported coverage), a modest negative signal for sentiment and analyst-driven buying. MetLife price target lowered to $98 from $100 at BofA

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.